- Easy Tracking In The Watchlist
Weaker technical forecast for Sigyn Therapeutics, Inc. as stock downgraded to Strong Sell Candidate
(Updated on Jun 03, 2026)
The Sigyn Therapeutics, Inc. stock price gained 3.56% on the last trading day (Wednesday, 3rd Jun 2026), rising from $0.0365 to $0.0378. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 0% from a day low at $0.0378 to a day high of $0.0378. The price has been going up and down for this period, and there has been a -4.3% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 15 thousand more shares were traded than the day before. In total, 17 thousand shares were bought and sold for approximately $642.60 .
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at -$0.414 is broken, it will firstly indicate a stronger fall rate. Due to the high volatility and the trend direction we are not able to give forecast range for this stock.
SIGY Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, May 15, 2026, and so far it has risen 8.00%. Further rise is indicated until a new top pivot has been found. Sigyn Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Sigyn Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.03. On a fall, the stock will find some support from the short-term average at $0.0372. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Sigyn Therapeutics, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.0359 and $0.0351. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Sigyn Therapeutics, Inc. finds support just below today's level at $0.0359. If this is broken, then the next support from accumulated volume will be at $0.0351 and $0.0350.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week, the stock has had daily average volatility of 3.83%.
Sigyn Therapeutics, Inc. is oversold on RSI14 (1). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (SIGY) For The Upcoming Trading Day Of Thursday 4th
For the upcoming trading day on Thursday, 4th we expect Sigyn Therapeutics, Inc. to open at $0.0378, and during the day (based on 14 day Average True Range), to move between $0 and $0.127, which gives a possible trading interval of +/-$0.179 (+/-127 324.72%) up or down from last closing price. If Sigyn Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 127 324.72% move between the lowest and the highest trading price during the day. ⚠️ Extreme Volatility Warning: The projected daily trading range exceeds 1000%, indicating exceptionally high volatility. This level of price movement suggests significant market uncertainty and elevated risk. Traders should exercise extreme caution, consider reduced position sizes, and implement strict risk management strategies when trading this security.
Since the stock is closer to the resistance from accumulated volume at $0.0380 (0.53%) than the support at $0.0359 (5.01%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Sigyn Therapeutics, Inc. stock A Buy?
Sigyn Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Current score:
-5.534
Strong Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on June 4, 2026 - $0.0378 ( 0%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
SIGY Performance
Trading levels for SIGY
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.0378 | - |
| R2 | 0.0378 | - |
| R1 | 0.0378 | - |
| Price | 0.0378 | |
| S1 | 0.0378 | - |
| S2 | 0.0378 | - |
| S3 | 0.0378 | - |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.0394 | 4.23% |
| R2 | 0.0390 | 3.17% |
| R1 | 0.0380 | 0.529% |
| Price | 0.0378 | |
| S1 | 0.0359 | -5.01% |
| S2 | 0.0351 | -7.14% |
| S3 | 0.0350 | -7.41% |
FAQ
Click here for our free guide on how to buy Sigyn Therapeutics, Inc. Stock.
Buy SIGY